Related Experiment Video
Updated: Jul 19, 2025
08:48
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
11.9K
Anticancer Potential of the Cyclolinopeptides.
Adnan Fojnica1,2, Zehra Gromilic2, Semir Vranic3
1Molecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, 8036 Graz, Austria.
Cancers
|August 12, 2023
Summary
Cyclolinopeptides (CLPs), natural compounds with low toxicity and cost, show significant potential as cancer therapeutics. Research indicates CLPs exhibit anti-cancer effects across various cell lines, offering a promising avenue for novel cancer treatments.
Area of Science:
- Natural product chemistry
- Cancer biology
- Pharmacology
Background:
- Current cancer treatments face limitations in efficacy and tolerability.
- Cyclolinopeptides (CLPs) are natural compounds with potential therapeutic applications.
- CLPs offer advantages such as high specificity, low toxicity, and cost-effectiveness.
Purpose of the Study:
- To provide an overview of the significance and potential of CLPs in cancer research.
- To emphasize the promising role of CLPs as therapeutic agents for cancer treatment.
- To review the effects of CLPs on various cancer cell lines.
Main Methods:
- In vitro studies on various cancer cell lines (breast cancer, gastric cancer, melanoma).
- Analysis of CLP effects on cancer cell proliferation, apoptosis, and angiogenesis.
- Investigation into the mechanisms of action of CLPs in cancer cells.
Main Results:
- CLPs demonstrated anti-proliferative, apoptotic, and anti-angiogenic effects in vitro.
- CLPs were shown to induce cell cycle arrest and inhibit cancer cell growth.
- Studies identified multifaceted mechanisms of action involving signaling pathways, protein kinases, and oxidative stress.
Conclusions:
- CLPs represent a significant potential for novel cancer therapeutics.
- The natural origin and favorable characteristics of CLPs support their development for cancer treatment.
- Further research into CLPs' mechanisms and efficacy is warranted for clinical application.
Related Concept Videos
02:39Positive Regulator Molecules
5.5K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.5K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
00:50Anaphase Promoting Complex
2.9K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.9K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K